Literature DB >> 19626675

DMPK protein isoforms are differentially expressed in myogenic and neural cell lineages.

Ralph J A Oude Ophuis1, Susan A M Mulders, René E M A van Herpen, Rinske van de Vorstenbosch, Bé Wieringa, Derick G Wansink.   

Abstract

Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder caused by an unstable (CTG . CAG)n segment in the 3' untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. It is commonly accepted that DMPK mRNA-based toxicity is the main contributor to DM1 manifestations; however, not much is known about the significance of the DMPK protein. To appreciate its normal and possible pathobiological role, we analyzed the patterns of DMPK splice isoform expression in mouse tissues. Long membrane-anchored DMPK dominated in heart, diaphragm, and skeletal muscle, whereas short cytosolic isoforms were highly expressed in bladder and stomach. Both isoform types were present in diverse brain regions. DMPK protein was also detectable in cultured myoblasts, myotubes, cortical astrocytes, and related cell lines of neural or muscle origin, but not in hippocampal neurons. This work identifies DMPK as a kinase with pronounced expression in diverse muscle and neural tissues that are affected in DM1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626675     DOI: 10.1002/mus.21352

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.

Authors:  Arturo López Castel; Masayuki Nakamori; Stephanie Tomé; David Chitayat; Geneviève Gourdon; Charles A Thornton; Christopher E Pearson
Journal:  Hum Mol Genet       Date:  2010-11-01       Impact factor: 6.150

2.  Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.

Authors:  Tetsuya Nagata; Chrissa A Dwyer; Kie Yoshida-Tanaka; Kensuke Ihara; Masaki Ohyagi; Hidetoshi Kaburagi; Haruka Miyata; Satoe Ebihara; Kotaro Yoshioka; Takashi Ishii; Kanjiro Miyata; Kenichi Miyata; Berit Powers; Tomoko Igari; Syunsuke Yamamoto; Naoto Arimura; Hideki Hirabayashi; Toshiki Uchihara; Rintaro Iwata Hara; Takeshi Wada; C Frank Bennett; Punit P Seth; Frank Rigo; Takanori Yokota
Journal:  Nat Biotechnol       Date:  2021-08-12       Impact factor: 68.164

3.  Characterization of the zebrafish homolog of zipper interacting protein kinase.

Authors:  Brandon W Carr; Tamara L Basepayne; Lawrence Chen; Vaishali Jayashankar; Douglas C Weiser
Journal:  Int J Mol Sci       Date:  2014-06-30       Impact factor: 5.923

4.  Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood.

Authors:  Lauren Buckley; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenomics       Date:  2016-01-12       Impact factor: 4.778

5.  A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.

Authors:  Anke E E G Gudde; Anchel González-Barriga; Walther J A A van den Broek; Bé Wieringa; Derick G Wansink
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

6.  CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.

Authors:  Ellen L van Agtmaal; Laurène M André; Marieke Willemse; Sarah A Cumming; Ingeborg D G van Kessel; Walther J A A van den Broek; Geneviève Gourdon; Denis Furling; Vincent Mouly; Darren G Monckton; Derick G Wansink; Bé Wieringa
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

7.  A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis.

Authors:  Ralph J A Oude Ophuis; Mietske Wijers; Miranda B Bennink; Fons A J van de Loo; Jack A M Fransen; Bé Wieringa; Derick G Wansink
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

8.  Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo.

Authors:  Ivica Grgic; Andreas F Hofmeister; Giulio Genovese; Andrea J Bernhardy; Hua Sun; Omar H Maarouf; Vanesa Bijol; Martin R Pollak; Benjamin D Humphreys
Journal:  Kidney Int       Date:  2014-06-18       Impact factor: 10.612

9.  Abnormalities of signal transduction networks in chronic schizophrenia.

Authors:  Jennifer L McGuire; Erica A Depasquale; Adam J Funk; Sinead M O'Donnovan; Kathryn Hasselfeld; Shruti Marwaha; John H Hammond; Vahram Hartounian; James H Meador-Woodruff; Jarek Meller; Robert E McCullumsmith
Journal:  NPJ Schizophr       Date:  2017-09-12

Review 10.  Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.

Authors:  Laurène M André; C Rosanne M Ausems; Derick G Wansink; Bé Wieringa
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.